semaglutide compound no longer available On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is considered in shortage, signaling an improvement in national supply. As a result, compounding Compounded Semaglutide Prescription - In

Glucagon-like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy

Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways: Weight loss - a major long-term treatment for IIH Possible CSF pressure effects - GLP-1 receptors on the choroid plexus (where CSF is made) may reduce fluid secretion independent of weight loss The IIH Pressure Trial ( Brain , 2023) found that exenatide lowered intracranial pressure within hours of the first dose

If you often feel tired despite sufficient rest, it might be worth considering your B12 levels

Chin J Physiol 10-31-2009;52(5):289-294